Lanreotide
is indicated for the long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or
radiotherapy
, or for whom surgery and/or radiotherapy is not an option.
The goal of treatment in acromegaly is to reduce (GH) and insuli growth factor-1 levels to normal.
Function
1)Treatment of acromegaly
(2)Treatment of certain tumors
(3)Radiolabeling in Nuclear Medicine Imaging
(4) Managing Bleeding Esophageal Varices
(5)Obesity
(6)Treatment of Gastrointestinal Fistula